SCM
ARCT icon

Sterling Capital Management’s Arcturus Therapeutics ARCT Stock Holding History

Sterling Capital Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.72K Sell
611
-350
-36% -$2.55K ﹤0.01% 2763
2025
Q4 		$5.89K Sell
961
-138
-13% -$1.49K ﹤0.01% 2836
2025
Q3 		$20.3K Buy
1,099
+654
+147% +$10.5K ﹤0.01% 2134
2025
Q2 		$5.79K Buy
445
+381
+595% +$4.5K ﹤0.01% 2430
2025
Q1 		$678 Sell
64
-41
-39% -$651 ﹤0.01% 2914
2024
Q4 		$1.78K Buy
105
+76
+262% +$1.43K ﹤0.01% 2810
2024
Q3 		$673 Buy
+29
New +$620 ﹤0.01% 2731

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return